How much does PT-141 cost through Peptide12?
Peptide12 lists compounded PT-141 injection from $129 per month on the 6-month plan. The monthly plan is listed at $229, and the 3-month plan is listed at $169 per month. Eligibility, state availability, and prescribing decisions still depend on clinician review.
Is PT-141 covered by insurance?
Coverage depends on the product, diagnosis, plan rules, and pharmacy benefit. Branded Vyleesi may be handled differently from compounded bremelanotide. Compounded medications are commonly cash-pay, so patients should ask what documentation is available for HSA, FSA, or reimbursement review.
Why are some PT-141 prices online much cheaper?
Very low prices may leave out clinician review, pharmacy dispensing, supplies, storage handling, follow-up, or quality documentation. Some sites sell research-use products without a prescription. Those products should not be treated as legitimate human medication.
What should PT-141 pricing include besides the vial?
A safer plan should include medical intake, contraindication screening, a prescription decision, pharmacy dispensing, supplies when needed, shipping terms, use limits, side-effect guidance, follow-up access, and clear cancellation or refill rules.
Is compounded PT-141 FDA-approved?
No. Vyleesi is the FDA-approved bremelanotide product for acquired, generalized HSDD in premenopausal women. Compounded PT-141 or bremelanotide may be prescribed for an individual patient when appropriate, but compounded products are not FDA-approved finished drugs.
What safety issue can make PT-141 the wrong choice?
The Vyleesi label says bremelanotide is contraindicated in people with uncontrolled hypertension or known cardiovascular disease. A clinician should also review blood pressure, medication history, pregnancy or breastfeeding, liver or kidney disease, nausea risk, and whether the symptoms match this treatment.